企業プロフィール
Protagonist Therapeutics Inc 株価・ニュース・カタリスト
- ティッカー:
- PTGX
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
158.62 USD (+2.27%)
終値
最終更新: 2026年8月17日
6B USD
時価総額
株価変動の要因
As of Aug 17, 2026, PTGX closed up 2.27% at $158.62. No new same-company headline was identified in the current news window.
企業概要
事業概要
Protagonist Therapeutics is a biotechnology company focused on peptide-based medicines and inflammatory disease. Its story is built around using peptide chemistry and targeted biology to address immune-mediated disorders.
所在地とセクター分類
Protagonist is headquartered in the United States and listed on NASDAQ. It sits in specialty immunology biotechnology.
ビジネスモデルの特徴
The company depends on clinical validation, partnership strategy, and the ability to create value from a focused pipeline. Investors watch data, launch prospects, and strategic updates.
バイオ業界での位置付け
Protagonist occupies a premium peptide-immunology niche within biotech. It has meaningful platform depth, but remains sensitive to clinical and partnership milestones.
今後のカタリスト
- Protagonist's catalysts are icotrokinra and the broader inflammatory-disease pipeline, where clinical and regulatory updates can materially move the stock. The company remains highly data-sensitive.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。